New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News Expert Discusses the Selection of Individuals for Germline Testing Based on Breast Cancer Risk Targeted Oncology News | October 2019 Home Genetic Testing Kits Sound like a Great Idea — Until They Aren’t Philadelphia Inquirer News | October 2019 Mathew Knowles Reveals He is Battling Breast Cancer Good Morning America News | October 2019 Meet the 2019 Breast Health Champions Philadelphia Magazine News | October 2019 Wellness Wednesday: Breast Cancer in Men WOSU Radio News | October 2019 What’s Your Family History? with Susan M. Domchek, MD Real Pink News | October 2019 Dr. Domchek on Potential Benefits of Biosimilars in Oncology OncLive News | September 2019 Penn’s Basser Center for BRCA Chooses Two Cambridge Researchers for 2019 Basser Global Prize Penn Medicine News News | September 2019 Broadening Criteria for BRCA1/2 Evaluation Placing the USPSTF Recommendation in Context Journal of the American Medical Association News | August 2019 Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic Sequencing American Society of Clinical Oncology Journal News | August 2019 Blackstone President Jonathan Gray Donates $25 Million To Tackle Deadly Breast Cancer Gene Forbes News | July 2019 Deputy Director of Penn’s Abramson Cancer Center Receives $3 Million Grant from The Gray Foundation Penn Medicine News News | July 2019 Women Proudly Model Bikinis After Body-Changing Battles New York Post News | July 2019 16 Things Doctors Wish You Knew About Breast Cancer Genetic Testing Reader's Digest News | June 2019 How Alejandra Campoverdi Outwitted Breast Cancer While Helping Women Save Their Own Lives People En Espanol News | June 2019 How Should Patients and Providers Interpret the US Food and Drug Administration’s Regulatory Language for Direct-to-Consumer Genetic Tests? Journal of Clinical Oncology News | June 2019 Trial Highlights Complexities of Targeted Therapy for Pancreatic Cancer National Cancer Institute News | June 2019 Doctors Outline New Discoveries in the Fight to Cure Ovarian Cancer Main Line Times News | May 2019 Pagination First page« First Previous page‹‹ … Page10 Page11 Page12 Page13 Current page14 Page15 Page16 Page17 Page18 Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
Expert Discusses the Selection of Individuals for Germline Testing Based on Breast Cancer Risk Targeted Oncology News | October 2019
Home Genetic Testing Kits Sound like a Great Idea — Until They Aren’t Philadelphia Inquirer News | October 2019
Penn’s Basser Center for BRCA Chooses Two Cambridge Researchers for 2019 Basser Global Prize Penn Medicine News News | September 2019
Broadening Criteria for BRCA1/2 Evaluation Placing the USPSTF Recommendation in Context Journal of the American Medical Association News | August 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic Sequencing American Society of Clinical Oncology Journal News | August 2019
Blackstone President Jonathan Gray Donates $25 Million To Tackle Deadly Breast Cancer Gene Forbes News | July 2019
Deputy Director of Penn’s Abramson Cancer Center Receives $3 Million Grant from The Gray Foundation Penn Medicine News News | July 2019
How Alejandra Campoverdi Outwitted Breast Cancer While Helping Women Save Their Own Lives People En Espanol News | June 2019
How Should Patients and Providers Interpret the US Food and Drug Administration’s Regulatory Language for Direct-to-Consumer Genetic Tests? Journal of Clinical Oncology News | June 2019
Trial Highlights Complexities of Targeted Therapy for Pancreatic Cancer National Cancer Institute News | June 2019
